Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies.

Current Drug Targets
Dileep Vijayan, Remya Chandra

Abstract

Alzheimer's disease (AD) is one of the most common forms of dementia and has been a global concern for several years. Due to the multi-factorial nature of the disease, AD has become irreversible, fatal and imposes a tremendous socio-economic burden. Even though experimental medicines suggested moderate benefits, AD still lacks an effective treatment strategy for the management of symptoms or cure. Among the various hypotheses that describe development and progression of AD, the amyloid hypothesis has been a long-term adherent to the AD due to the involvement of various forms of Amyloid beta (Aβ) peptides in the impairment of neuronal and cognitive functions. Hence, majority of the drug discovery approaches in the past have focused on the prevention of the accumulation of Aβ peptides. Currently, there are several agents in the phase III clinical trials that target Aβ or the various macromolecules triggering Aβ deposition. In this review, we present the state of the art knowledge on the functional aspects of the key players involved in the amyloid hypothesis. Furthermore, we also discuss anti-amyloid agents present in the Phase III clinical trials.

References

Feb 1, 1986·Annals of Neurology·S M Rothman, J W Olney
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·G MerliniP Garini
Jan 1, 1995·Alzheimer Disease and Associated Disorders·C Geula, M M Mesulam
Jan 1, 1997·Free Radical Biology & Medicine·W R Markesbery
Oct 28, 1998·Journal of Physiology, Paris·N C Inestrosa, R Alarcón
Feb 5, 1999·Progress in Brain Research·H BraakE Braak
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·W SongB A Yankner
Nov 24, 1999·Molecular and Cellular Neurosciences·I HussainG Christie
Jul 11, 2000·Nature Medicine·B V ZlokovicB Frangione
Jul 11, 2000·Nature Medicine·B V ZlokovicB Frangione
Aug 25, 2000·The Journal of Biological Chemistry·B D BennettR Vassar
Jun 8, 2001·The American Journal of Pathology·D M MannUNKNOWN Members of the Familial Alzheimer's Disease Pathology Study Group
Jun 12, 2001·Current Opinion in Neurobiology·S Cull-CandyM Farrant
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·R B DeMattosD M Holtzman
Jul 7, 2001·The Journal of Biological Chemistry·W E Van NostrandG W Rebeck
Jul 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·P DoerflerR M Perlmutter
Nov 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·S KitazumeY Hashimoto
Sep 12, 2002·Archives of Neurology·Hiroaki FukumotoMichael C Irizarry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Michael DonohueRobert A Rissman
Recent Patents on CNS Drug Discovery
Mamta Sapra, Kye Y Kim
© 2021 Meta ULC. All rights reserved